Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Marvell Technology Inc ha un obiettivo di prezzo di consenso pari a $100.35, stabilito in base alle ultime valutazioni degli analisti di 31. Le ultime 3 valutazioni degli analisti sono state rilasciate da Morgan Stanley, Goldman Sachs y Cantor Fitzgerald il julio 30, 2025, julio 10, 2025 y junio 18, 2025. Con un obiettivo di prezzo medio di $76.67 tra le Morgan Stanley, Goldman Sachs y Cantor Fitzgerald, c'è un implicito 0.15% upside per Marvell Technology Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/30/2025 | 4.51% | Morgan Stanley | $73 → $80 | Maintains | Equal-Weight | |||
07/10/2025 | -2.02% | Goldman Sachs | → $75 | Initiates | → Neutral | |||
06/18/2025 | -2.02% | Cantor Fitzgerald | $60 → $75 | Maintains | Neutral | |||
06/18/2025 | 50.23% | B. Riley Securities | $110 → $115 | Maintains | Buy | |||
06/18/2025 | -0.72% | Melius Research | $67 → $76 | Maintains | Hold | |||
06/18/2025 | 17.57% | B of A Securities | $80 → $90 | Maintains | Buy | |||
06/18/2025 | 24.1% | Benchmark | $95 → $95 | Reiterates | Buy → Buy | |||
06/18/2025 | 11.04% | Needham | $85 → $85 | Reiterates | Buy → Buy | |||
06/18/2025 | 61.99% | Rosenblatt | $124 → $124 | Maintains | Buy | |||
06/05/2025 | 43.7% | China Renaissance | — | → $110 | Initiates | → Buy | ||
05/30/2025 | -5.94% | B of A Securities | $72 → $72 | Maintains | Buy | |||
05/30/2025 | -4.64% | Morgan Stanley | $70 → $73 | Maintains | Equal-Weight | |||
05/30/2025 | 17.57% | Loop Capital | $110 → $90 | Maintains | Buy | |||
05/30/2025 | 11.04% | Deutsche Bank | $100 → $85 | Maintains | Buy | |||
05/30/2025 | 17.57% | Raymond James | $110 → $90 | Reiterates | Outperform → Outperform | |||
05/30/2025 | 73.74% | Evercore ISI Group | $135 → $133 | Maintains | Outperform | |||
05/30/2025 | 11.04% | Piper Sandler | $95 → $85 | Reiterates | Overweight → Overweight | |||
05/30/2025 | 17.57% | Keybanc | $115 → $90 | Maintains | Overweight | |||
05/30/2025 | 24.1% | Wells Fargo | $120 → $95 | Maintains | Overweight | |||
05/30/2025 | -21.62% | Cantor Fitzgerald | $60 → $60 | Reiterates | Neutral → Neutral | |||
05/30/2025 | 61.99% | Rosenblatt | $124 → $124 | Maintains | Buy | |||
05/30/2025 | 24.1% | Benchmark | $95 → $95 | Reiterates | Buy → Buy | |||
05/30/2025 | 11.04% | Needham | $100 → $85 | Maintains | Buy | |||
05/28/2025 | -12.48% | Melius Research | $66 → $67 | Maintains | Neutral | |||
05/28/2025 | -12.48% | Redburn Atlantic | → $67 | Initiates | → Neutral | |||
05/27/2025 | -8.56% | Morgan Stanley | $90 → $70 | Maintains | Equal-Weight | |||
05/27/2025 | 17.57% | Susquehanna | $110 → $90 | Maintains | Positive | |||
05/22/2025 | -13.78% | Melius Research | $66 → $66 | Downgrade | Buy → Hold | |||
05/19/2025 | 30.63% | UBS | $110 → $100 | Maintains | Buy | |||
05/07/2025 | 24.1% | Benchmark | $135 → $95 | Maintains | Buy | |||
05/07/2025 | -21.62% | Cantor Fitzgerald | $125 → $60 | Downgrade | Overweight → Neutral | |||
04/22/2025 | 4.51% | Barclays | $130 → $80 | Maintains | Overweight | |||
04/17/2025 | 4.51% | Stifel | $115 → $80 | Maintains | Buy | |||
04/16/2025 | -5.94% | B of A Securities | $120 → $72 | Maintains | Buy | |||
04/11/2025 | 25.41% | Citigroup | $122 → $96 | Maintains | Buy | |||
03/06/2025 | 43.7% | UBS | $125 → $110 | Maintains | Buy | |||
03/06/2025 | 56.76% | Wells Fargo | $140 → $120 | Maintains | Overweight | |||
03/06/2025 | 43.7% | Raymond James | $130 → $110 | Maintains | Outperform | |||
03/06/2025 | 17.57% | Morgan Stanley | $113 → $90 | Maintains | Equal-Weight | |||
03/06/2025 | 50.23% | Stifel | $130 → $115 | Maintains | Buy | |||
03/06/2025 | 59.37% | Citigroup | $136 → $122 | Maintains | Buy | |||
03/06/2025 | 43.7% | Loop Capital | → $110 | Upgrade | Hold → Buy | |||
03/06/2025 | 24.1% | Piper Sandler | $120 → $95 | Maintains | Overweight | |||
03/06/2025 | 69.82% | Barclays | $150 → $130 | Maintains | Overweight | |||
03/06/2025 | 50.23% | Keybanc | $135 → $115 | Maintains | Overweight | |||
03/06/2025 | 56.76% | B of A Securities | $150 → $120 | Maintains | Buy | |||
03/06/2025 | 76.36% | Benchmark | $135 → $135 | Reiterates | Buy → Buy | |||
03/06/2025 | 82.89% | Rosenblatt | $140 → $140 | Maintains | Buy | |||
03/06/2025 | 30.63% | Needham | $120 → $100 | Maintains | Buy | |||
02/24/2025 | 63.29% | UBS | $115 → $125 | Maintains | Buy | |||
01/28/2025 | 47.62% | Morgan Stanley | $120 → $113 | Maintains | Equal-Weight | |||
01/22/2025 | 76.36% | Keybanc | $125 → $135 | Maintains | Overweight | |||
01/17/2025 | 95.95% | Barclays | $115 → $150 | Maintains | Overweight | |||
01/13/2025 | 82.89% | Susquehanna | $125 → $140 | Maintains | Positive | |||
01/13/2025 | 82.89% | Wells Fargo | $130 → $140 | Maintains | Overweight | |||
01/10/2025 | 71.13% | Goldman Sachs | $115 → $131 | Maintains | Buy | |||
01/06/2025 | 94.64% | Craig-Hallum | $132 → $149 | Maintains | Buy | |||
01/06/2025 | 69.82% | Stifel | $125 → $130 | Maintains | Buy | |||
12/20/2024 | 56.76% | Morgan Stanley | $102 → $120 | Maintains | Equal-Weight | |||
12/05/2024 | 50.23% | Goldman Sachs | $87 → $115 | Maintains | Buy | |||
12/04/2024 | 69.82% | JP Morgan | $90 → $130 | Maintains | Overweight | |||
12/04/2024 | 43.7% | Loop Capital | $95 → $110 | Maintains | Hold | |||
12/04/2024 | 46.31% | Citigroup | $91 → $112 | Maintains | Buy | |||
12/04/2024 | 76.36% | Cantor Fitzgerald | $120 → $135 | Reiterates | Overweight → Overweight | |||
12/04/2024 | 63.29% | Keybanc | $95 → $125 | Maintains | Overweight | |||
12/04/2024 | 50.23% | UBS | $110 → $115 | Maintains | Buy | |||
12/04/2024 | 72.44% | Craig-Hallum | $88 → $132 | Maintains | Buy | |||
12/04/2024 | 63.29% | Oppenheimer | $110 → $125 | Reiterates | Outperform → Outperform | |||
12/04/2024 | 56.76% | Piper Sandler | $100 → $120 | Reiterates | Overweight → Overweight | |||
12/04/2024 | 63.29% | Susquehanna | $110 → $125 | Maintains | Positive | |||
12/04/2024 | 63.29% | Stifel | $114 → $125 | Reiterates | Buy → Buy | |||
12/04/2024 | 33.25% | Morgan Stanley | $82 → $102 | Maintains | Equal-Weight | |||
12/04/2024 | 65.9% | Evercore ISI Group | $122 → $127 | Maintains | Outperform | |||
12/04/2024 | 63.29% | B of A Securities | $108 → $125 | Maintains | Buy | |||
12/04/2024 | 82.89% | Rosenblatt | $120 → $140 | Maintains | Buy | |||
12/04/2024 | 76.36% | Benchmark | $115 → $135 | Reiterates | Buy → Buy | |||
12/04/2024 | 56.76% | Needham | $95 → $120 | Maintains | Buy | |||
12/04/2024 | 50.23% | Barclays | $85 → $115 | Maintains | Overweight | |||
12/02/2024 | 59.37% | Evercore ISI Group | $98 → $122 | Maintains | Outperform | |||
11/27/2024 | 43.7% | Susquehanna | $95 → $110 | Maintains | Positive | |||
11/26/2024 | 43.7% | Oppenheimer | $90 → $110 | Maintains | Outperform | |||
11/26/2024 | 43.7% | Wells Fargo | $90 → $110 | Maintains | Overweight | |||
11/11/2024 | 24.1% | Loop Capital | → $95 | Initiates | → Hold | |||
10/14/2024 | 18.88% | Citigroup | $91 → $91 | Maintains | Buy | |||
08/30/2024 | 56.76% | Rosenblatt | $100 → $120 | Maintains | Buy | |||
08/30/2024 | 17.57% | B of A Securities | $85 → $90 | Maintains | Buy | |||
08/30/2024 | 50.23% | Benchmark | $105 → $115 | Maintains | Buy | |||
08/30/2024 | 11.04% | Cantor Fitzgerald | $85 → $85 | Reiterates | Overweight → Overweight | |||
08/30/2024 | 11.04% | Barclays | $80 → $85 | Maintains | Overweight | |||
08/30/2024 | 30.63% | Piper Sandler | $100 → $100 | Reiterates | Overweight → Overweight | |||
08/30/2024 | 13.65% | Goldman Sachs | $77 → $87 | Maintains | Buy | |||
08/30/2024 | 24.1% | Stifel | $90 → $95 | Reiterates | Buy → Buy | |||
08/30/2024 | 28.02% | Evercore ISI Group | $91 → $98 | Maintains | Outperform | |||
08/30/2024 | 24.1% | Roth MKM | $95 → $95 | Maintains | Buy | |||
08/30/2024 | 7.12% | Morgan Stanley | $77 → $82 | Maintains | Equal-Weight | |||
08/30/2024 | 24.1% | Needham | $95 → $95 | Reiterates | Buy → Buy | |||
08/22/2024 | 30.63% | Rosenblatt | $100 → $100 | Maintains | Buy | |||
07/09/2024 | 24.1% | Keybanc | $90 → $95 | Maintains | Overweight | |||
05/31/2024 | 4.51% | Barclays | $75 → $80 | Maintains | Overweight | |||
05/31/2024 | 17.57% | Oppenheimer | $80 → $90 | Reiterates | Outperform → Outperform |
El último precio objetivo de Marvell Tech (NASDAQ:MRVL) fue comunicado por Morgan Stanley el julio 30, 2025. La firma de analistas fijó un precio objetivo para $80.00 que espera MRVL a rise dentro de 12 meses (un posible 4.51% upside). 97 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Marvell Tech (NASDAQ:MRVL) fue proporcionada por Morgan Stanley, y Marvell Tech mantuvo su equal-weight calificación.
La última revisión al alza de Marvell Technology Inc se produjo en marzo 6, 2025, cuando Loop Capital elevó su precio objetivo a $110. Loop Capital anteriormente tenía a hold para Marvell Technology Inc.
La última revisión a la baja de Marvell Technology Inc se produjo en mayo 22, 2025, cuando Melius Research cambió su precio objetivo de $66 a $66 para Marvell Technology Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Marvell Tech, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Marvell Tech se registró el julio 30, 2025, por lo que la próxima calificación estará disponible en torno al julio 30, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Marvell Tech (MRVL) fue un mantuvo con un precio objetivo de $73.00 a $80.00. El precio actual al que cotiza Marvell Tech (MRVL) es de $76.55, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.